Editorial: Innate Anti-Tumor Immune Responses in Solid and Hematological Malignancies: From Basic Research to Clinical Applications

Bibliographic Details
Main Authors: Anne-Sophie Chretien, Nicolas Dulphy, Emanuela Marcenaro
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.957119/full
_version_ 1828810527627804672
author Anne-Sophie Chretien
Anne-Sophie Chretien
Nicolas Dulphy
Nicolas Dulphy
Emanuela Marcenaro
author_facet Anne-Sophie Chretien
Anne-Sophie Chretien
Nicolas Dulphy
Nicolas Dulphy
Emanuela Marcenaro
author_sort Anne-Sophie Chretien
collection DOAJ
first_indexed 2024-12-12T09:13:15Z
format Article
id doaj.art-430f2694ffc84e6db1e3b4578c310fc9
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-12T09:13:15Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-430f2694ffc84e6db1e3b4578c310fc92022-12-22T00:29:27ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-06-011310.3389/fimmu.2022.957119957119Editorial: Innate Anti-Tumor Immune Responses in Solid and Hematological Malignancies: From Basic Research to Clinical ApplicationsAnne-Sophie Chretien0Anne-Sophie Chretien1Nicolas Dulphy2Nicolas Dulphy3Emanuela Marcenaro4Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University UM105, Marseille, FranceImmunomonitoring Department, Institut Paoli-Calmettes, Marseille, FranceUniversité Paris Cité, Institut de Recherche Saint Louis, Inserm U1160, Paris, FranceLaboratoire d'Immunologie et d'Histocompatibilité, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, FranceDepartment of Experimental Medicine, University of Genova, Genova, Italyhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.957119/fullinnate immunitynatural killer cellshematological malignanciessolid tumorviral infectionimmunotherapy
spellingShingle Anne-Sophie Chretien
Anne-Sophie Chretien
Nicolas Dulphy
Nicolas Dulphy
Emanuela Marcenaro
Editorial: Innate Anti-Tumor Immune Responses in Solid and Hematological Malignancies: From Basic Research to Clinical Applications
Frontiers in Immunology
innate immunity
natural killer cells
hematological malignancies
solid tumor
viral infection
immunotherapy
title Editorial: Innate Anti-Tumor Immune Responses in Solid and Hematological Malignancies: From Basic Research to Clinical Applications
title_full Editorial: Innate Anti-Tumor Immune Responses in Solid and Hematological Malignancies: From Basic Research to Clinical Applications
title_fullStr Editorial: Innate Anti-Tumor Immune Responses in Solid and Hematological Malignancies: From Basic Research to Clinical Applications
title_full_unstemmed Editorial: Innate Anti-Tumor Immune Responses in Solid and Hematological Malignancies: From Basic Research to Clinical Applications
title_short Editorial: Innate Anti-Tumor Immune Responses in Solid and Hematological Malignancies: From Basic Research to Clinical Applications
title_sort editorial innate anti tumor immune responses in solid and hematological malignancies from basic research to clinical applications
topic innate immunity
natural killer cells
hematological malignancies
solid tumor
viral infection
immunotherapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.957119/full
work_keys_str_mv AT annesophiechretien editorialinnateantitumorimmuneresponsesinsolidandhematologicalmalignanciesfrombasicresearchtoclinicalapplications
AT annesophiechretien editorialinnateantitumorimmuneresponsesinsolidandhematologicalmalignanciesfrombasicresearchtoclinicalapplications
AT nicolasdulphy editorialinnateantitumorimmuneresponsesinsolidandhematologicalmalignanciesfrombasicresearchtoclinicalapplications
AT nicolasdulphy editorialinnateantitumorimmuneresponsesinsolidandhematologicalmalignanciesfrombasicresearchtoclinicalapplications
AT emanuelamarcenaro editorialinnateantitumorimmuneresponsesinsolidandhematologicalmalignanciesfrombasicresearchtoclinicalapplications